Lumen Technologies Inc vs Tenet Healthcare Corporation — how do they compare? Lumen Technologies Inc trades at $5.28 (market cap $5.73B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 3.7× Lumen Technologies Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Lumen Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lumen Technologies Inc for 40 Days and Tenet Healthcare Corporation for 15 Days on average.
| LUMN | THC | |
|---|---|---|
Market Cap | $5.73B | $20.98B |
Volume | 17,079,799 | 428,008 |
Sector | Media | Health |
52-Week High | $11.83 | $280.77 |
52-Week Low | $5.53 | $161.37 |
Typical Hold Time | 40 Days | 15 Days |
Enterprise Value | $17.35B | $32.06B |
Signals from Pluang's Aura AI — not financial advice
LUMN trades at $5.56, down 5.92% on the day, reflecting ongoing investor caution amid weak profitability and high debt. The stock shows a bearish technical trend with key support at $5.00, while fundamentals reveal declining revenue, negative net income margins, and a challenging turnaround effort. Recent news highlights a Nasdaq listing move and AI-focused networking initiatives, but legacy telecom declines persist.
Outlook remains speculative with high execution risk; the company's deep value (P/S 0.47) and AI growth potential contrast with consistent losses and substantial leverage. Analyst consensus is Reduce, with 60.7% Hold ratings, signaling limited near-term confidence despite strategic pivots.
Tenet Healthcare (THC) trades at $260.57, showing modest daily gains of 0.28% with strong technical support at $257 and resistance at $262. The stock demonstrates robust fundamentals with a P/E of 10.07, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights the upcoming Q3 2026 earnings release on October 29, 2026, while the company maintains strong cash flow generation of $3.54 billion from operations.
THC presents a compelling investment case with 81% analyst buy ratings and a $283.36 consensus price target representing 8.7% upside potential. The company's expanding capital return strategy and projected revenue growth to $22.6 billion in 2026 support bullish sentiment, though investors should monitor surgical volume trends and capital allocation sustainability as key risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →